explore -WSS

explore

author：entertainment 2025-09-06 03:54:10 - browse：6252

Kara Coluccio, a managing partner at Perspective Group poses for a portrait. -- health coverage from STAT — Kara Coluccio, a managing partner at Perspective Group, says the job market for biotech executives has gotten much tighter. Jessica Rinaldi/Globe Staff

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup.

Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy. But pharmaceutical companies are large and complex, and she craved more immediate impact. “I was looking for a place where I could be in the room,” she says. She wanted more autonomy, and to feel like her work would reach patients sooner.

At the time, biotech startups were rolling in cash and seeking to capture some of the magic that had fueled Moderna’s meteoric rise. They handed out lots of logo-embossed swag. “Investors were putting a lot of money into stupid science,” Byers says. “There were a lot of companies that lasted for a lot longer than I thought they would on very little data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Celiac disease study examines precisely how gluten triggers injury

WSS

Involuntary treatment for addiction doesn't work

A disappointing year of Humira biosimilars

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Industry veterans launch new biotech VC with $310M

Vaccine advisory panel ACIP left half staffed by HHS

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

knowledge

explore

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A disappointing year of Humira biosimilars

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare threatens to cut off funding for HCA's Mission hospital

The high cost of giving birth even with insurance

Industry veterans launch new biotech VC with $310M

The high cost of giving birth even with insurance

Biden report: The neurospychology of memory and aging

Novavax promises a turnaround & Lilly roils the obesity market

Does aspartame cause cancer? What new WHO guidance says

knowledge

Industry veterans launch new biotech VC with $310M

Eli Lilly to acquire Versanis in heated race for weight loss drugs

The dental labor crisis is a moment of opportunity

Blood tests recalled over risk of missed heart attack diagnosis

Biogen Alzheimer’s drug launch off to slow start

Gilead might be held responsible for not developing a drug

focus

knowledge

explore

hotspot